Former CEO of OptimizeRx to Put Millions of Dollars in Prescription Savings Right Into the Hands of Those Americans Looking for Relief
September 08, 2022 08:46 ET
|
TranspareRx Corporation
NAPLES, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Former OptimizeRx CEO and founder David Harrell today announced the launch of his newest endeavor, TranspareRx. The company aims to bring full...
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, Allianz, GoodRx, and the WWE and Encourages Investors to Contact the Firm
July 15, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Allianz, TrueBlue, and GoodRx and Encourages Investors to Contact the Firm
July 10, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Allianz SE (OTCMKTS:...
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, the WWE, Digital World, and Generac and Encourages Investors to Contact the Firm
July 04, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, July 04, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc....
Bragar Eagel & Squire, P.C. Is Investigating TrueBlue, NeoGenomics, GoodRx, and Ebix and Encourages Investors to Contact the Firm
June 29, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 29, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TrueBlue, Inc. (NYSE:...
Bragar Eagel & Squire, P.C. Is Investigating GoodRx, Cassava, Ebix, and the WWE and Encourages Investors to Contact the Firm
June 24, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoodRx Holdings, Inc....
Bragar Eagel & Squire, P.C. Is Investigating TG Therapeutics, GoodRx, Agrify, and Pegasystems and Encourages Investors to Contact the Firm
June 03, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, June 03, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TG Therapeutics, Inc....
Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
May 22, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 22, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS:...
Bragar Eagel & Squire, P.C. Is Investigating Clariant, TG Therapeutics, Coinbase, and GoodRx and Encourages Investors to Contact the Firm
May 16, 2022 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Clariant AG (OTCMKTS:...
ROSEN, LEADING INVESTOR COUNSEL, Reminds GoodRx Holdings, Inc. Investors of Important February 16 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – GDRX
December 28, 2020 19:14 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September 23, 2020...